You’re eating pretty much the same way. Your weight may not have changed dramatically. Maybe you’re even exercising more than you used to.
Then you get your routine bloodwork back and suddenly your cholesterol is higher.
Your LDL cholesterol has climbed. Your triglycerides may look different. Perhaps your doctor tells you to keep an eye on your cardiovascular health, even though your previous cholesterol results were perfectly normal.
If you’re in your 40s or early 50s, there may be another piece of the puzzle worth considering: perimenopause.
Perimenopause is often associated with hot flashes, irregular periods, mood changes, and sleep problems. But the hormonal changes happening during this transition can also affect metabolism, body composition, blood sugar regulation, and cholesterol.
In other words, perimenopause isn’t only a reproductive transition. It can also be a cardiometabolic transition.
Understanding what’s happening can help you make more informed decisions about your health during this stage of life.
Why Does Cholesterol Change During Perimenopause?
Perimenopause is the transition leading up to menopause, and it can last for several years.
During this time, estrogen and progesterone do not simply decline in a smooth, predictable way. Hormone levels can fluctuate considerably before eventually settling into the lower levels associated with menopause.
These hormonal changes affect much more than your menstrual cycle.
Estrogen interacts with the liver, blood vessels, fat tissue, glucose metabolism, and other systems involved in cardiovascular health. As estrogen levels become more variable and eventually decline, cholesterol and other metabolic markers can begin to shift.
Research following women through the menopause transition has found increases in total cholesterol, LDL cholesterol, and apolipoprotein B (ApoB) around menopause.
That means the cholesterol changes you’re seeing on your bloodwork may not simply be the result of eating more saturated fat or exercising less. Your changing hormonal environment may be contributing too.
The Estrogen-Cholesterol Connection
Estrogen has several effects that influence cardiovascular and metabolic health.
Before menopause, estrogen helps regulate lipid metabolism and supports healthy blood vessel function. As estrogen declines, the way the liver processes cholesterol and lipoproteins can change.
This may contribute to increases in:
- LDL cholesterol, commonly called “bad” cholesterol
- ApoB, a marker reflecting the number of potentially atherogenic lipoprotein particles
- Total cholesterol
- Triglycerides in some women
- Changes in the size and distribution of cholesterol-carrying particles
Interestingly, HDL cholesterol, often called “good” cholesterol, can sometimes remain stable or even increase during the menopause transition. However, cardiovascular risk is more complicated than simply wanting HDL to be high.
Research suggests that the composition and function of HDL particles may also change during menopause. This is one reason why looking at cardiovascular health through a single cholesterol number can miss part of the picture.
Perimenopause Can Affect More Than Cholesterol
One of the most important things to understand about this stage of life is that cholesterol changes rarely happen in isolation.
The menopause transition can also be accompanied by changes in insulin sensitivity, blood pressure, body composition, and fat distribution.
Some women notice that their waistline changes even when the number on the scale barely moves. Fat may begin accumulating more readily around the abdomen and internal organs.
This visceral fat is metabolically active. Higher levels are associated with insulin resistance, inflammation, elevated triglycerides, and greater cardiovascular risk.
You may therefore see several changes happening around the same time:
Your LDL starts creeping upward.
Your fasting glucose isn’t quite as good as it used to be.
Your waist circumference increases.
Your blood pressure changes.
Losing weight becomes more difficult.
These changes are not necessarily separate problems. They may be different signs of a changing cardiometabolic environment.
What Does Blood Sugar Have to Do With Cholesterol?
Insulin resistance occurs when your cells become less responsive to insulin, the hormone responsible for helping move glucose from your bloodstream into your cells.
When insulin sensitivity declines, the liver may produce more triglyceride-rich particles. This can contribute to higher triglycerides and changes in lipoprotein patterns.
Poor sleep, chronic stress, loss of muscle mass, reduced physical activity, genetics, dietary patterns, and increasing visceral fat can all influence insulin sensitivity during midlife.
That is why a functional medicine approach to cholesterol often looks beyond cholesterol itself.
If LDL has suddenly increased during perimenopause, it may be useful to ask:
What else has changed metabolically?
Your Standard Cholesterol Panel May Not Tell the Whole Story
A standard lipid panel is an important starting point. It usually includes total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.
Depending on your personal and family history, a healthcare professional may also consider additional markers to better understand cardiovascular and metabolic risk.
These may include:
Apolipoprotein B (ApoB): ApoB can provide information about the number of cholesterol-carrying particles capable of contributing to plaque formation.
Lipoprotein(a), or Lp(a): This is a largely genetically determined cardiovascular risk marker. Because lifestyle usually has a limited effect on Lp(a), testing it can reveal inherited risk that might otherwise go unnoticed.
Hemoglobin A1c and fasting glucose: These provide information about blood sugar regulation.
Blood pressure and waist circumference: These simple measurements provide valuable information about cardiometabolic health.
Additional testing may sometimes be appropriate depending on symptoms, medical history, medications, and overall cardiovascular risk.
The goal is not to order every possible test. It is to gather enough useful information to understand your individual risk and determine what deserves attention.
What About Hormone Testing?
If you suspect perimenopause, it may seem logical to simply test estrogen and progesterone and see whether they’re “low.”
But hormones can fluctuate considerably during perimenopause. A single estrogen measurement represents one moment in time and may not accurately reflect what has been happening throughout the month.
For many women over 45 with typical symptoms and menstrual changes, perimenopause can often be identified clinically rather than through extensive hormone testing.
Testing may still be appropriate in certain situations, particularly when symptoms are unusual, periods stop unexpectedly early, or another medical condition needs to be ruled out.
Can You Improve Cholesterol During Perimenopause?
Absolutely. Hormonal changes may influence your cholesterol, but that does not mean cardiovascular decline is inevitable.
Perimenopause is actually an excellent time to become more proactive about long-term metabolic and cardiovascular health.
Prioritize Protein and Fibre
Adequate protein supports muscle mass, which becomes increasingly important for metabolic health as we age.
Fibre, particularly soluble fibre from foods such as oats, beans, lentils, vegetables, fruit, nuts, and seeds, can support healthier LDL cholesterol levels.
Rather than focusing exclusively on what needs to be removed from your diet, consider what your meals need more of.
More plants. More fiber. More minimally processed foods. Enough protein. Healthy sources of unsaturated fats.
Pay Attention to Saturated Fat
Some people experience a stronger LDL response to saturated fat than others.
If LDL or ApoB has increased significantly, it can be worth reviewing how much saturated fat is coming from foods such as butter, high-fat dairy, fatty meats, coconut oil, and heavily processed foods.
Replacing some saturated fats with unsaturated fats from foods such as olive oil, nuts, seeds, avocado, and fish may help improve the overall lipid profile.
Build and Maintain Muscle
Strength training becomes especially valuable during perimenopause.
Muscle is not just about strength or appearance. It is metabolically active tissue that plays an important role in glucose regulation and insulin sensitivity.
Aim to incorporate regular resistance training alongside cardiovascular activity and everyday movement.
Don’t Ignore Sleep
Night sweats, insomnia, and frequent waking are common during perimenopause, but poor sleep can have consequences beyond feeling tired the next morning.
Chronic sleep disruption can affect appetite regulation, glucose metabolism, stress hormones, blood pressure, and food choices.
Addressing sleep problems may therefore be an important part of improving overall cardiometabolic health.
Manage the Stress Load
Stress doesn’t automatically cause high cholesterol, but chronic stress can influence many of the systems that affect metabolic health.
It can interfere with sleep, make blood sugar regulation more difficult, influence eating patterns, and make it harder to maintain consistent movement and exercise.
Stress management doesn’t need to mean adding another complicated wellness routine to your schedule. Walking, spending time outdoors, breathing exercises, therapy, social connection, and simply creating more recovery time can all be useful.
Should You Consider Menopausal Hormone Therapy?
Menopausal hormone therapy can be very effective for appropriate women experiencing symptoms such as hot flashes and night sweats.
It can also influence lipid and metabolic markers.
However, hormone therapy should not be viewed simply as a treatment for high cholesterol or a strategy for preventing cardiovascular disease.
Whether hormone therapy is appropriate depends on factors including your age, symptoms, time since menopause, personal and family medical history, cardiovascular risk, and other health considerations.
Perimenopause Is an Opportunity to Get Proactive
Finding out that your cholesterol has increased can be frustrating, particularly when you feel like you haven’t done anything differently.
But your body is going through something different.
Perimenopause changes the hormonal environment that influences metabolism, cholesterol, blood sugar, body composition, and cardiovascular health. Recognizing those changes gives you an opportunity to respond thoughtfully rather than waiting until those risk factors become bigger problems.
If you’ve noticed changes in your cholesterol, weight, energy, blood sugar, sleep, or other metabolic markers during perimenopause, a more comprehensive evaluation may help you understand what is happening and what you can do about it.
We can take a closer look at your health history, symptoms, lifestyle, and relevant laboratory markers to develop a personalized plan for supporting your health through perimenopause and beyond.
References
Anagnostis, P., & Stevenson, J. C. (2024). Cardiovascular health and the menopause, metabolic health. Best Practice & Research Clinical Endocrinology & Metabolism, 38(1), 101781. https://doi.org/10.1016/j.beem.2023.101781
El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., Allison, M. A., & American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention. (2020). Menopause transition and cardiovascular disease risk: Implications for timing of early prevention. Circulation, 142(25), e506–e532. https://doi.org/10.1161/CIR.0000000000000912
El Khoudary, S. R., Hutchins, P. M., Matthews, K. A., Brooks, M. M., Orchard, T. J., Ronsein, G. E., & Heinecke, J. W. (2021). HDL subclasses, lipid content, and function trajectories across the menopause transition: SWAN-HDL study. Arteriosclerosis, Thrombosis, and Vascular Biology, 41(2), 951–961. https://doi.org/10.1161/ATVBAHA.120.315355
El Khoudary, S. R., Nasr, A., Matthews, K. A., Orchard, T. J., Brooks, M. M., & Thurston, R. C. (2023). Low-density lipoprotein subclasses over the menopausal transition and risk of coronary calcification and carotid atherosclerosis: The SWAN Heart and HDL ancillary studies. Menopause, 30(11), 1117–1125. https://doi.org/10.1097/GME.0000000000002245
Inaraja, V., Thuissard, I., Andreu-Vazquez, C., & Jodar, E. (2020). Lipid profile changes during the menopausal transition. Menopause, 27(7), 780–787. https://doi.org/10.1097/GME.0000000000001532
Karlamangla, A. S., Burnett-Bowie, S. A. M., & Crandall, C. J. (2023). Bone health during the menopause transition and beyond. Obstetrics and Gynecology Clinics of North America, 50(4), 689–708.
Matthews, K. A., Crawford, S. L., Chae, C. U., Everson-Rose, S. A., Sowers, M. F., Sternfeld, B., & Sutton-Tyrrell, K. (2009). Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of the American College of Cardiology, 54(25), 2366–2373. https://doi.org/10.1016/j.jacc.2009.10.009
Thurston, R. C., El Khoudary, S. R., Sutton-Tyrrell, K., Crandall, C. J., Gold, E. B., Sternfeld, B., Joffe, H., Selzer, F., & Matthews, K. A. (2012). Vasomotor symptoms and lipid profiles in women transitioning through menopause. Obstetrics & Gynecology, 119(4), 753–761. https://doi.org/10.1097/AOG.0b013e31824a09ec